4-o-methyl-12-o-tetradecanoylphorbol 13-acetate has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albani, D; Batelli, S; De Mauro, S; De Ronchi, D; Forloni, G; Kalofoutis, A; Liappas, I; Mailis, A; Malitas, P; Olgiati, P; Piperi, C; Politis, A; Polito, L; Serretti, A; Signorini, A; Stamouli, E; Zisaki, A | 1 |
| Abeti, R; Abramov, AY; Duchen, MR | 1 |
2 other study(ies) available for 4-o-methyl-12-o-tetradecanoylphorbol 13-acetate and Alzheimer Disease
| Article | Year |
|---|---|
Vitamin B12 levels in Alzheimer's disease: association with clinical features and cytokine production.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Apolipoprotein E4; Cytokines; Female; Follow-Up Studies; Humans; Lymphocytes; Male; Mental Status Schedule; Neuropsychological Tests; Radioimmunoassay; Tetradecanoylphorbol Acetate; Up-Regulation; Vitamin B 12 | 2010 |
Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death.
Topics: 4-Chloro-7-nitrobenzofurazan; Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Animals; Animals, Newborn; Astrocytes; Calcium; Cell Death; Coculture Techniques; Deoxyglucose; Disease Models, Animal; Glial Fibrillary Acidic Protein; Glucose; Hippocampus; Membrane Potential, Mitochondrial; Mice; Mice, Transgenic; NAD; NADPH Oxidases; Neurons; Oxygen Consumption; Peptide Fragments; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Tetradecanoylphorbol Acetate | 2011 |